Virtu Financial LLC - PASITHEA THERAPEUTICS CORP ownership

PASITHEA THERAPEUTICS CORP's ticker is and the CUSIP is 70261F103. A total of 12 filers reported holding PASITHEA THERAPEUTICS CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Virtu Financial LLC ownership history of PASITHEA THERAPEUTICS CORP
ValueSharesWeighting
Q3 2023$7
-12.5%
15,469
-8.6%
0.00%0.0%
Q2 2023$8
+33.3%
16,929
+13.9%
0.00%0.0%
Q1 2023$6
-70.0%
14,864
-52.0%
0.00%
-66.7%
Q4 2022$20
-99.9%
30,937
+112.3%
0.00%
+200.0%
Q2 2022$15,00014,5710.00%
Other shareholders
PASITHEA THERAPEUTICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
NAPLES GLOBAL ADVISORS, LLC 10,620$5,0950.00%
XTX Topco Ltd 10,726$5,1450.00%
MARK SHEPTOFF FINANCIAL PLANNING, LLC 3,323$1,5940.00%
Virtu Financial LLC 15,469$70.00%
ROYAL BANK OF CANADA 5,000$2,0000.00%
UBS Group AG 83$400.00%
WELLS FARGO & COMPANY/MN 151$720.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 125,123$60,0560.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 38,568$18,5010.00%
View complete list of PASITHEA THERAPEUTICS CORP shareholders